Rekombinant aktiveret protein C: fra evidens til klinisk praksis. Kliniske retningslinjer for brug af aktiveret protein C ved svaer sepsis

Lars Heslet; Jørn Dalsgaard Nielsen; Jens Schierbeck; Jakob Steen Andersen

Rekombinant aktiveret protein C: fra evidens til klinisk praksis. Kliniske retningslinjer for brug af aktiveret protein C ved svaer sepsis

Lars Heslet, Jørn Dalsgaard Nielsen, Jens Schierbeck, Jakob Steen Andersen

2 Citationer (Scopus)

Bidragets oversatte titel	Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	166
Udgave nummer	11
Sider (fra-til)	997-1002
Antal sider	6
ISSN	0041-5782
Status	Udgivet - 8 mar. 2004

Emneord

Anti-Infective Agents/adverse effects
Contraindications
Evidence-Based Medicine
Fibrinolytic Agents/adverse effects
Hemorrhage/chemically induced
Humans
Monitoring, Physiologic
Patient Selection
Practice Guidelines as Topic
Protein C/adverse effects
Recombinant Proteins/adverse effects
Risk Factors
Sepsis/diagnosis
Severity of Illness Index

Citationsformater

@article{822a0c2fa1244669b1ae8c05dbef058d,

title = "Rekombinant aktiveret protein C: fra evidens til klinisk praksis. Kliniske retningslinjer for brug af aktiveret protein C ved svaer sepsis",

keywords = "Anti-Infective Agents/adverse effects, Contraindications, Evidence-Based Medicine, Fibrinolytic Agents/adverse effects, Hemorrhage/chemically induced, Humans, Monitoring, Physiologic, Patient Selection, Practice Guidelines as Topic, Protein C/adverse effects, Recombinant Proteins/adverse effects, Risk Factors, Sepsis/diagnosis, Severity of Illness Index",

author = "Lars Heslet and Nielsen, {J{\o}rn Dalsgaard} and Jens Schierbeck and Andersen, {Jakob Steen}",

year = "2004",

month = mar,

day = "8",

language = "Dansk",

volume = "166",

pages = "997--1002",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "11",

}

TY - JOUR

T1 - Rekombinant aktiveret protein C

T2 - fra evidens til klinisk praksis. Kliniske retningslinjer for brug af aktiveret protein C ved svaer sepsis

AU - Heslet, Lars

AU - Nielsen, Jørn Dalsgaard

AU - Schierbeck, Jens

AU - Andersen, Jakob Steen

PY - 2004/3/8

Y1 - 2004/3/8

KW - Anti-Infective Agents/adverse effects

KW - Contraindications

KW - Evidence-Based Medicine

KW - Fibrinolytic Agents/adverse effects

KW - Hemorrhage/chemically induced

KW - Humans

KW - Monitoring, Physiologic

KW - Patient Selection

KW - Practice Guidelines as Topic

KW - Protein C/adverse effects

KW - Recombinant Proteins/adverse effects

KW - Risk Factors

KW - Sepsis/diagnosis

KW - Severity of Illness Index

M3 - Review

C2 - 15049234

SN - 0041-5782

VL - 166

SP - 997

EP - 1002

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 11

ER -